MALVERN, Pa., Oct. 25, 2024 /PRNewswire/ -- Endo, Inc. announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) in patients with Peyronie's disease will be shared during SurgeWest, the 100th annual meeting of the...
Endo Announces Peyronie's Disease Presentation at the SurgeWest Annual Meeting of the Western Section of the American Urological Association
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments